Related Experiment Video
Updated: Mar 12, 2026

09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
15.7K
Targeted Magnetic Liposomes Loaded with Doxorubicin
Pallab Pradhan1,2,3, Rinti Banerjee4, Dhirendra Bahadur5
1Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India. pallab.pradhan@bme.gatech.edu.
Methods in Molecular Biology (Clifton, N.J.)
|November 13, 2016
Summary
Researchers developed novel folate receptor-targeted magnetic liposomes encapsulating doxorubicin for enhanced cancer therapy. These targeted nanoparticles enable site-specific drug delivery and hyperthermia-induced release, improving efficacy and reducing side effects.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Targeted drug delivery is crucial for maximizing anticancer efficacy and minimizing systemic toxicity.
- Conventional chemotherapy faces challenges due to non-specific distribution and severe side effects.
- Novel strategies are needed to improve drug accumulation at tumor sites.
Purpose of the Study:
- To prepare and characterize folate receptor-targeted magnetic liposomes encapsulating doxorubicin.
- To investigate the potential of these liposomes for dual-mode tumor targeting (magnetic and biological).
- To explore hyperthermia-induced drug release and MRI traceability for advanced cancer treatment.
Main Methods:
- Preparation of doxorubicin-loaded liposomes functionalized with folate receptors.
- Incorporation of magnetic nanoparticles for magnetic targeting.
- Characterization using various analytical techniques.
- Evaluation of drug release under alternating magnetic field for hyperthermia.
Main Results:
- Successful preparation of targeted magnetic liposomes encapsulating doxorubicin.
- Demonstrated potential for dual-mode targeting via folate receptors and magnetic fields.
- Evidence of hyperthermia-mediated drug release.
- Confirmation of MRI traceability for imaging applications.
Conclusions:
- Folate receptor-targeted magnetic liposomes offer a promising platform for enhanced doxorubicin delivery in cancer therapy.
- The dual-targeting strategy combined with triggered release and MRI traceability represents a significant advancement in nanomedicine.
- Further in vivo studies are warranted to validate the therapeutic potential and safety profile.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K

